In vivo imaging of neuromodulation using positron emission tomography: Optimal ligand characteristics and task length for detection of activation

被引:52
作者
Morris, ED
Fisher, RE
Alpert, NM
Rauch, SL
Fischman, AJ
机构
[1] MASSACHUSETTS GEN HOSP,DEPT RADIOL,BOSTON,MA 02114
[2] MASSACHUSETTS GEN HOSP,DEPT PSYCHIAT,BOSTON,MA 02114
[3] HARVARD UNIV,SCH MED,BOSTON,MA
关键词
endogenous; dopamine; receptor; activation; mathematical model; optimization;
D O I
10.1002/hbm.460030105
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Considerable evidence suggests that cognitive state affects local levels of neurotransmitter in the brain. We introduce a compartment model of neuroreceptor ligand kinetics to describe the effect of change in cognitive state on positron emission tomography (PET) signal dynamics. The model is used to establish optimal experimental conditions, timing of activation, and ligand characteristics, for detecting cognitive activation. The model, which follows free and bound endogenous neurotransmitter, describes the PET curve predicted for a single injection of radioligand in the presence or absence of activation. Activation was conceptualized as the performance of a task that raises the level of neurotransmitter that competes for receptor sites with the radioligand. Simulating the dopamine system, for example, required making assumptions regarding the kinetic rate constants for binding/dissociation of endogenous dopamine to/from the receptor and dopamine concentrations in the synapse. Simulations suggest that activation of dopamine should be detectable with PET and the D2 receptor ligand [C-11]raclopride, although this ligand might not be optimal. Aspects of experimental design can be modified to optimize the likelihood of detecting neurotransmitter changes. The ideal radioligand for these studies should bind irreversibly to its receptor. Furthermore, the task should commence at injection time and last for at least 7 minutes. Optimal task duration depends on the dynamics of free radioligand in the tissue and can be determined via model simulations for any well-characterized receptor ligand. Flow effects were shown to be distinguishable from those of neurotransmitter activation. General principles regarding desirable ligand characteristics and activation timing held for both the D2 receptor and the dopamine transporter site. (C) 1995 Wiley-Liss, Inc.
引用
收藏
页码:35 / 55
页数:23
相关论文
共 24 条
[1]   WORKSHOP ON SCHIZOPHRENIA, PET, AND DOPAMINE D2 RECEPTORS IN THE HUMAN NEOSTRIATUM [J].
ANDREASEN, NC ;
CARSON, R ;
DIKSIC, M ;
EVANS, A ;
FARDE, L ;
GJEDDE, A ;
HAKIM, A ;
LAL, S ;
NAIR, N ;
SEDVALL, G ;
TUNE, L ;
WONG, D .
SCHIZOPHRENIA BULLETIN, 1988, 14 (03) :471-484
[2]   MODELS FOR INVIVO KINETIC INTERACTIONS OF DOPAMINE D2-NEURORECEPTORS AND 3-(2'-[F-18]FLUOROETHYL)SPIPERONE EXAMINED WITH POSITRON EMISSION TOMOGRAPHY [J].
BAHN, MM ;
HUANG, SC ;
HAWKINS, RA ;
SATYAMURTHY, N ;
HOFFMAN, JM ;
BARRIO, JR ;
MAZZIOTTA, JC ;
PHELPS, ME .
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 1989, 9 (06) :840-849
[3]   LOCALIZATION OF DOPAMINE CARRIERS BY BTCP, A DOPAMINE UPTAKE INHIBITOR, ON NIGRAL CELLS CULTURED INVITRO [J].
CERRUTI, C ;
DRIAN, MJ ;
KAMENKA, JM ;
PRIVAT, A .
BRAIN RESEARCH, 1991, 555 (01) :51-57
[4]  
Childress A. R., 1993, Society for Neuroscience Abstracts, V19, P1864
[5]   IDENTIFIABILITY ANALYSIS AND PARAMETER-IDENTIFICATION OF AN INVIVO LIGAND-RECEPTOR MODEL FROM PET DATA [J].
DELFORGE, J ;
SYROTA, A ;
MAZOYER, BM .
IEEE TRANSACTIONS ON BIOMEDICAL ENGINEERING, 1990, 37 (07) :653-661
[6]   EFFECTS OF CENTRAL CHOLINERGIC BLOCKADE ON STRIATAL DOPAMINE RELEASE MEASURED WITH POSITRON EMISSION TOMOGRAPHY IN NORMAL HUMAN-SUBJECTS [J].
DEWEY, SL ;
SMITH, GS ;
LOGAN, J ;
BRODIE, JD ;
SIMKOWITZ, P ;
MACGREGOR, RR ;
FOWLER, JS ;
VOLKOW, ND ;
WOLF, AP .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (24) :11816-11820
[7]  
DEWEY SL, 1992, J NEUROSCI, V12, P3773
[8]   AMPHETAMINE INDUCED DECREASES IN (F-18)-N-METHYLSPIROPERIDOL BINDING IN THE BABOON BRAIN USING POSITRON EMISSION TOMOGRAPHY (PET) [J].
DEWEY, SL ;
LOGAN, J ;
WOLF, AP ;
BRODIE, JD ;
ANGRIST, B ;
FOWLER, JS ;
VOLKOW, ND .
SYNAPSE, 1991, 7 (04) :324-327
[9]  
DUNCAN J S, 1992, Neurology, V42, P297
[10]  
FARDE L, 1987, ARCH GEN PSYCHIAT, V44, P671